Expanded access to funded shingles vaccine

The federal government has expanded access to the shingles vaccineto cover individuals aged 18 to 64 who are at a moderate to high risk of herpes zoster as advised by the ATAGI.

Leanne Raven, Chief Executive Office, Crohn’s and Colitis Australia said that Australians living with auto-immune diseases such as Crohn’s or Ulcerative colitis need as much support as possible to avoid developing conditions that can further impact their day-to-day life. 

“This is especially important for those who have to take certain immunosuppressants, as they are at an even greater risk of developing other health conditions such as infections, or cardiovascular disease depending on their treatment.”

Patients are encouraged to talk to their GP or gastroentorologist about their eligibility for this vaccine.  

Read more here: